PDS Biotechnology
PDSB
PDSB
80 hedge funds and large institutions have $39.9M invested in PDS Biotechnology in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.81% more ownership
Funds ownership: 24.93% → 25.74% (+0.81%)
19% less capital invested
Capital invested by funds: $49.4M → $39.9M (-$9.53M)
Holders
80
Holding in Top 10
–
Calls
$1.47M
Puts
$1.36M
Top Buyers
| 1 | +$6.4M | |
| 2 | +$1.78M | |
| 3 | +$1.64M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.43M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$944K |
Top Sellers
| 1 | -$3.67M | |
| 2 | -$2.91M | |
| 3 | -$1.79M | |
| 4 |
Renaissance Technologies
New York
|
-$1.72M |
| 5 |
First Manhattan
New York
|
-$1.67M |